Safety and Efficacy of Eculizumab in High-risk TA-TMA

Clinical trial NCT07707687 · RECRUITING

Trial details

NCT number: NCT07707687
Sponsor: First Affiliated Hospital of Zhejiang University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Transplant-Associated Thrombotic Microangiopathy (TA-TMA)

Start date: 2026-07-10
Primary completion: 2028-07-10
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.